Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DREAM Tech, LLC is a biotechnology and scientific consulting company that specializes in quantitative chemical risk assessment and advanced dose-response modeling software. Spun out of Indiana University, the company provides a proprietary web-based platform known as Bayesian Benchmark Dose (BBMD), which utilizes Bayesian statistical frameworks to evaluate toxicological data. Their technology is primarily designed to support pharmaceutical drug development and regulatory safety evaluations by providing precise distributional estimates for chemical toxicity. The company's solutions help researchers and regulatory bodies streamline the translation of preclinical data into human health guidance. DREAM Tech has been supported by multiple grants from the National Institutes of Health (NIH), including the National Center for Advancing Translational Sciences (NCATS).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DREAM Tech.